Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 1
2013 2
2014 1
2015 1
2016 2
2017 4
2018 7
2019 12
2020 23
2021 27
2022 19
2023 39
2024 36

Text availability

Article attribute

Article type

Publication date

Search Results

161 results

Results by year

Filters applied: . Clear all
Page 1
Developing combination therapies with biologics in triple-negative breast cancer.
Gaudio G, Martino E, Pellizzari G, Cavallone M, Castellano G, Omar A, Katselashvili L, Trapani D, Curigliano G. Gaudio G, et al. Among authors: trapani d. Expert Opin Biol Ther. 2024 Oct 3:1-20. doi: 10.1080/14712598.2024.2408756. Online ahead of print. Expert Opin Biol Ther. 2024. PMID: 39360776 Review.
Reply to S. Najem et al.
El Bairi K, Trapani D. El Bairi K, et al. Among authors: trapani d. JCO Glob Oncol. 2024 Sep;10:e2400331. doi: 10.1200/GO-24-00331. JCO Glob Oncol. 2024. PMID: 39303194
Exploring a Novel Approach to Spare Classic Chemotherapy in HER2-Low, ER-Positive Breast Cancer Based on Trastuzumab Deruxtecan Combined with Endocrine Therapy.
Scafuri L, Buonerba C, Di Lauro V, Tortora V, Cascella M, Liguori L, Sciarra A, Sabbatino F, Diana A, Marra A, Tarantino P, Trapani D, Giuliano M, Arpino G, Curigliano G, Di Lorenzo G. Scafuri L, et al. Among authors: trapani d. Oncol Ther. 2024 Sep;12(3):363-373. doi: 10.1007/s40487-024-00286-3. Epub 2024 Jun 28. Oncol Ther. 2024. PMID: 38941050 Free PMC article.
Standardized molecular pathology workflow for ctDNA-based ESR1 testing in HR+/HER2- metastatic breast cancer.
Guerini-Rocco E, Venetis K, Cursano G, Mane E, Frascarelli C, Pepe F, Negrelli M, Olmeda E, Vacirca D, Ranghiero A, Trapani D, Criscitiello C, Curigliano G, Rolfo C, Malapelle U, Fusco N. Guerini-Rocco E, et al. Among authors: trapani d. Crit Rev Oncol Hematol. 2024 Sep;201:104427. doi: 10.1016/j.critrevonc.2024.104427. Epub 2024 Jun 23. Crit Rev Oncol Hematol. 2024. PMID: 38917944 Review.
161 results